In this review, we will discuss what is known, what is suspected, and what still remains
obscure about the central role played by coreceptor expression and usage in the …

Human immunodeficiency virus is undoubtedly the causative agent of AIDS. The
understanding of HIV-1 pathogenesis is essentiell to develop and maintain antiretroviral …

Viral tropism is the ability of viruses to enter and infect specific host cells and is based on the
ability of viruses to bind to receptors on those cells. Testing for HIV tropism is recommended …

C. Proteolytic Processing of Structural Proteins D. Proteolytic Processing of Nonstructural
Proteins E. Cis-Acting RNA Sequences Required for Replication F. Mechanism of RNA …

Topical agents, such as microbicides, that can protect against human immunodeficiency
virus (HIV) transmission are urgently needed. Using a chimeric simian/human …

The third variable region, V3, of the gp120 surface envelope glycoprotein is an
approximately 35-residue-long, frequently glycosylated, highly variable, disulfide-bonded …

Fusion inhibitors are a new class of antiretroviral drugs (ARVs) for the treatment of human
immunodeficiency virus infection. Enfuvirtide is the first in this class to reach market …

Inhibitors of human immunodeficiency virus type 1 (HIV-1) enzymes are central to the
treatment of HIV-1 infection, but the development of resistant viruses remains a problem …

Rotavirus entry into a cell is a complex multistep process in which different domains of the
rotavirus surface proteins interact with different cell surface molecules, which act as …

Identification of cellular factors involved in HIV-1 entry and transmission at mucosal surfaces
is critical for understanding viral pathogenesis and development of effective prevention …